Showing 1611-1620 of 2526 results for "".
- Companies in US Drug Supply Chain Unveil Pilot Project to Track Counterfeit Medicineshttps://modernod.com/news/companies-in-us-drug-supply-chain-unveil-pilot-project-to-track-counterfeit-medicines/2477315/Several companies, including Pfizer, GlaxoSmithKline, Roche, Eli Lilly, Novartis, Sanofi, Novo Nordisk, Amgen and Gilead Sciences, have created a blockchain-based platform to track prescription products across the supply chain in an effort to better stem the flow of counterfeit medicines, a
- SECO 20/20 Unveils Exclusive Lineup of “Special Sessions”https://modernod.com/news/seco-20-20-unveils-exclusive-lineup-of-special-sessions/2477292/SECO 20/20 has announced the list of 11 speakers who will be featured during the event’s Special Sessions. From March 4-8, 2020, SECO 20/20 will bring together optometric professionals from around the globe to discuss the latest innovations, while discovering cutting-edge lab techniques and infor
- Santen and Verily Establish Joint Venture to Develop and Commercialize Unique Ophthalmic Deviceshttps://modernod.com/news/santen-and-verily-establish-joint-venture-to-develop-and-commercialize-unique-ophthalmic-devices/2477285/Santen Pharmaceutical and Alphabet subsidiary Verily announced the establishment of a joint venture focused on applying microelectronics and scalable digital technologies to ophthalmology. The new joint venture is driven by a mission to improve eye health for people everywhere, starting by
- Staar Surgical Announces the EVO Implantable Lens US Clinical Trial is Underwayhttps://modernod.com/news/staar-surgical-announces-the-evo-implantable-lens-us-clinical-trial-is-underway/2477273/Staar Surgical announced the first patient was implanted in the company’s US human clinical study for its EVO ICL family of lenses. The investigational study, “A Multicenter Clinical Evaluation of the EVO/EVO+ Visian Implantable Collamer Lens,” will be conducted at more than a dozen ophthalmology
- USRetina Announces RetinaOS To Help Practices Better Understand and Manage Business Efficientlyhttps://modernod.com/news/usretina-announces-retinaos-to-help-retina-practices-understand-and-manage-the-business-efficiently/2477257/USRetina announced new technology offerings it says will drive more value for retina practices. USRetina’s new cloud-based platform, known as RetinaOS, includes RetinaInventory, an inventory management and practice data consolidation solution, and RetinaPurchasing, a group purchasing portal that
- Quick Eye Test May Flag Unrecognized Brain Injuryhttps://modernod.com/news/quick-eye-test-may-flag-unrecognized-brain-injury/2477145/A quick, noninvasive, handheld device that detects changes in pupil size may offer rapid assessment of potential brain injury in young athletes who have sustained a high-impact hit to the head but who exhibit no obvious signs of brain injury, according to a
- Largest Study of Chinese Americans Uncovers Unique Risk Factors for Visual Impairmenthttps://modernod.com/news/largest-study-of-chinese-americans-uncovers-unique-risk-factors-for-visual-impairment/2477019/CHA Hollywood Presbyterian Medical Center (CHA HPMC) announced publication of a study by Rohit Varma, MD, MPH, director of its Southern California Eye Institute, assessing risk factors for vision impairment in Chinese Americans. The largest study on Chinese Americans to date, “Factors Associated
- Optos Unveils Silverstone Combined Ultra-Widefield Retinal Imaging Device and UWF-Guided Swept Source OCThttps://modernod.com/news/optos-unveils-silverstone-combined-ultra-widefield-retinal-imaging-device-and-uwf-guided-swept-source-oct/2476998/Optos has announced the launch of Silverstone at the American Academy of Ophthalmology in San Francisco. Silverstone is the first-of-its-kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. Silverstone produces a 200° single capture
- Ocutrx Unveils ORLenz for Surgery Visualization Technology in ARWear Headsethttps://modernod.com/news/ocutrx-unveils-orlenz-for-surgery-visualization-technology-in-arwear-headset/2476972/Ocutrx Vision Technologies is revealing a next-generation AR headset technology for surgery visualization called the ORLenz. A prototype of this technology is being formally introduced at the American Academy of Ophthalmology 2019 Conference in San Francisco. The ORLenz is a second medical device
- Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa in the European Unionhttps://modernod.com/news/aerie-pharmaceuticals-receives-positive-chmp-opinion-for-rhokiinsa-in-the-european-union/2476906/Aerie Pharmaceuticals announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of the marketing authorization application (MAA) for Rhokiinsa (netarsudilophthalmic solution) 0.02%. The recommend